Core Insights - Biotech stocks experienced significant gains in after-hours trading on September 9, 2025, driven by clinical updates, insider buying, and investor conference appearances across several small- and mid-cap companies [1] Company Summaries - **Immutep Ltd. (IMMP)**: Shares rose by 4.37% to $1.67 after-hours, following a decline of 6.98% during regular trading. The stock's rebound was fueled by the acceptance of data from its EFTISARC-NEO Phase II trial for oral presentation at CTOS 2025, focusing on a rare cancer with high unmet need [2][3] - **Nautilus Biotechnology Inc. (NAUT)**: Shares surged by 12.25% to $0.7521 after-hours, recovering from a 4.42% decline in regular trading. The increase was attributed to insider buying by CEO Sujal M. Patel, who purchased 83,500 shares, signaling confidence in the company [4][5] - **Pliant Therapeutics Inc. (PLRX)**: The stock ended regular trading at $1.75, up 1.16%, and jumped 16.00% to $2.03 after-hours. The upcoming third-quarter earnings report on November 6, 2025, is expected to provide updates on its lead candidate targeting idiopathic pulmonary fibrosis [6][7] - **Jin Medical International Ltd. (ZJYL)**: Shares closed at $0.6532, gaining 3.65% during regular trading and rising 7.15% to $0.6999 after-hours. The catalyst for this movement was the announcement of expanded production capabilities in China, aimed at enhancing global delivery of medical equipment [7][8] - **Phio Pharmaceuticals Corp. (PHIO)**: The stock rose 8.20% to $2.64 after-hours, building on a 13.49% increase during regular trading. The momentum was driven by participation in the H.C. Wainwright 27th Annual Global Investment Conference, where updates on its Phase 1b clinical trial for PH-762 will be presented [8][9] - **Kura Oncology Inc. (KURA)**: Shares increased by 6.12% to $8.50 after-hours, following a 1.60% decline in regular trading. The rally was linked to the company's presentation at the H.C. Wainwright conference, highlighting key developments and upcoming regulatory milestones for Ziftomenib [10][11][12]

Group 1 - The stock of Zhongjin Medical (ZJYL) opened up by 10.51% on August 25, reaching $0.8 per share, with a total transaction volume of $47,700 and a market capitalization of $125 million [1] - As of March 31, 2025, Zhongjin Medical reported total revenue of $9.8815 million, a year-on-year decrease of 6.4%, and a net profit attributable to the parent company of -$89,000, representing a year-on-year decrease of 104.96% [1] - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that primarily operates through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd., which was established in January 2006 and has been recognized as a national high-tech enterprise since 2012 [1] Group 2 - The company specializes in the research and manufacturing of high-end rehabilitation equipment, having developed into a top-tier global manufacturer over more than a decade [1] - Its product range includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment specifically designed for the elderly and special populations, as well as disaster relief products [1]

Core Viewpoint - Zhongjin Medical (ZJYL) experienced a significant stock price increase of 22.4% on August 23, reaching $0.699 per share, with a trading volume of $309,400 and a total market capitalization of $109 million [1] Financial Performance - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57% [1] - The net profit attributable to the parent company was $3.6759 million, showing a year-on-year increase of 27.71% [1] Company Overview - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that primarily operates through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd. [1] - The subsidiary was established in January 2006 and has been recognized as a national high-tech enterprise since 2012 [1] - The company specializes in the research and manufacturing of high-end rehabilitation equipment and has developed into a leading global manufacturer in this sector over more than a decade [1] - Its product range includes walking aids, respiratory medical devices, smart nano bathing equipment, specialized bathing products for the elderly and patients, fitness equipment for the elderly and special populations, and disaster relief products [1]

Group 1 - The stock of Zhongjin Medical (ZJYL) opened up by 6.79% on August 22, reaching $0.61 per share, with a total market capitalization of $95.4781 million [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57%, and a net profit attributable to the parent company of $3.6759 million, reflecting a year-on-year increase of 27.71% [1] - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that primarily operates through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd., which has been recognized as a national high-tech enterprise since 2012 [1] Group 2 - The company specializes in the research and manufacturing of high-end rehabilitation equipment, having developed into a top-tier global manufacturer over more than a decade [1] - Its product range includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment specifically designed for the elderly and special populations, as well as disaster relief products [1]

Group 1 - The stock price of Zhongjin Medical (ZJYL) increased by 3.57% on August 22, reaching $0.592 per share, with a trading volume of $23,100 and a total market capitalization of $92.5976 million [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57%, and a net profit attributable to the parent company of $3.6759 million, reflecting a year-on-year increase of 27.71% [1] - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that primarily operates through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd., which has been recognized as a high-tech enterprise since 2012 [1] Group 2 - The company specializes in the research and manufacturing of high-end rehabilitation equipment, having developed into a top-tier global manufacturer over more than a decade [1] - Its product range includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment for the elderly and special populations, as well as disaster relief products [1]

Group 1 - The core viewpoint of the article highlights the positive financial performance of Zhongjin Medical (ZJYL), with a stock price increase of 2.15% and a market capitalization of approximately $98.09 million [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.50 million, representing a year-on-year growth of 18.57% [1] - The company's net profit attributable to shareholders reached $3.68 million, reflecting a year-on-year increase of 27.71% [1] Group 2 - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that operates primarily through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd. [1] - The subsidiary was established in January 2006 and has been recognized as a national high-tech enterprise since 2012 [1] - The company specializes in the research and manufacturing of high-end rehabilitation equipment, with a product range that includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment for the elderly and special populations [1]

Group 1 - The stock price of Zhongjin Medical (ZJYL) increased by 5.62% on August 13, reaching $0.672 per share, with a total market capitalization of $10.5 million [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57%, and a net profit attributable to the parent company of $3.6759 million, reflecting a year-on-year increase of 27.71% [1] - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company primarily operating through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd., which has been recognized as a national high-tech enterprise since 2012 [1] Group 2 - The company specializes in the research and manufacturing of high-end rehabilitation equipment, having developed into a top-tier global manufacturer over more than a decade [1] - Its product range includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment for the elderly and special populations, as well as disaster relief products [1]

Group 1 - The core viewpoint of the article highlights the positive financial performance of Zhongjin Medical (ZJYL), with a stock price increase of 2.78% and a market capitalization of $103 million as of August 8 [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57% [1] - The net profit attributable to the parent company reached $3.6759 million, showing a year-on-year increase of 27.71% [1] Group 2 - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that operates primarily through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd. [1] - The subsidiary was established in January 2006 and has been recognized as a national high-tech enterprise since 2012 [1] - The company specializes in the research and manufacturing of high-end rehabilitation equipment, with a product range that includes walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment for the elderly and special populations [1]

Core Viewpoint - Zhongjin Medical (ZJYL) has shown a significant increase in stock price and positive financial performance, indicating strong growth potential in the rehabilitation equipment industry [1] Financial Performance - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57% [1] - The net profit attributable to the parent company reached $3.6759 million, with a year-on-year increase of 27.71% [1] Company Overview - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company, primarily operating through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd. [1] - The subsidiary was established in January 2006 and has been recognized as a national high-tech enterprise since 2012 [1] - The company specializes in the research and manufacturing of high-end rehabilitation equipment, having developed into a leading global player in this sector over more than a decade [1] Product Range - Zhongjin Medical's product offerings include walking aids, respiratory medical devices, smart nano bathing equipment, and fitness equipment for the elderly and special populations, as well as disaster relief products [1]

Group 1 - The core viewpoint of the article highlights the positive financial performance of Zhongjin Medical (ZJYL), with a stock price increase of 2.19% and a market capitalization of $102 million as of July 30 [1] - As of September 30, 2024, Zhongjin Medical reported total revenue of $23.502 million, representing a year-on-year growth of 18.57% [1] - The net profit attributable to the parent company reached $3.6759 million, showing a year-on-year increase of 27.71% [1] Group 2 - Zhongjin Medical Equipment International Co., Ltd. is a Cayman Islands-registered holding company that operates primarily through its domestic subsidiary, Changzhou Zhongjin Medical Equipment Co., Ltd. [1] - The subsidiary was established in January 2006 and has been recognized as a national high-tech enterprise since 2012 [1] - The company specializes in the research and development, as well as manufacturing of high-end rehabilitation equipment, and has developed into a top-tier global player in this sector over more than a decade [1]